Summary The National Diabetes Research Strategy (2026–2035) presents a unified national vision to transform Australia’s response to diabetes through a comprehensive forward-looking research and innovation agenda. It is grounded in
Summary People with type 2 diabetes mellitus (T2DM) have increased risk of dysmetabolic liver disease and liver fibrosis, linked with increased morbidity and mortality. In recent years, non-invasive methods for
Summary Developed by an expert working group of representatives from the Australian Diabetes Society (ADS), Australian Diabetes Educators Association (ADEA), Royal Australian College of General Practitioners (RACGP) and Dietitians Australia,
Summary A joint guideline by the Australian Diabetes Society (ADS) and Australian and New Zealand Society of Nuclear Medicine (ANZSNM) for PET/CT imaging in patients with type 1 and type
Summary A consensus clinical practice recommendation endorsed by the Australian Diabetes Society (ADS), National Association of Clinical Obesity Services (NACOS), Gastroenterological Society of Australia (GESA) and Australian and New Zealand
Summary The blood glucose management algorithm for type 2 diabetes outlines the risks, benefits and costs of available therapies and provides an approach for how to incorporate older and newer
Summary Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus Position Statement The use of glycated haemoglobin (HbA1c) for diagnosis of diabetes mellitus has been
Summary The ADS together with ADEA and ANZCA have made an update to the Alert – ‘Periprocedural Diabetic Ketoacidosis (DKA) with SGLT2 Inhibitor use in People with Diabetes’ incorporating recently published
ADS Position Statement ‘Medical Certification of Persons with Insulin-treated Diabetes in the Aviation Industry’ This is the first ADS supported position statement to address medical certification of diabetes in
The prevalence of diabetes is rising and so too is the complexity of diabetes management. There is an increasing number of diabetes medication classes and of medications within each of
